Latest News from EMD

Nearly 200 people attended the Yale Institute for Global Health’s (YIGH) inaugural Global Health Symposium on April 5. The day-long event featured opportunities to learn about YIGH programs, including seed grants, faculty networks, and fellowship opportunities for students. There was also a session on how to navigate Yale's policies to support global health programs, and lightning talks on a wide variety of faculty and student initiatives in global health.

Women's Health Research at Yale Investigator Akiko Iwasaki, PhD, has been named to the TIME100, TIME Magazine's annual list of the most influential people of the year from around the world.

Instead of drugs that must be taken daily, scientists are closing in on longer-acting alternatives — perhaps even a future in which H.I.V. may require attention just twice a year, inconceivable in the darkest decades of the epidemic. Featuring Yale School of Public Health's Gregg Gonsalves.

This series spotlights the amazing students in the YSPH Epidemiology of Microbial Diseases (EMD) program. This month, we are focusing on students who are conducting vaccine-related research. Here, Alyssa Agarwal, BS ’24, MPH ’25, tells us about the program and some of her exciting research in a Q&A format.

This series spotlights the amazing students in the YSPH Epidemiology of Microbial Diseases (EMD) program. This month focuses on students who are conducting vaccine-related research. Here, Mallory Ellingson Ph.D. 24’, tells us about the program and some of her exciting research in a Q&A format.

A Yale-led study finds that older adults who had contact with young children daily or every few days were six times more likely to carry the bacteria that causes pneumonia than older adults who had no contact with children.

Harlan Krumholz, MD, Harold H. Hines, Jr. Professor of Medicine (Cardiology), and Akiko Iwasaki, PhD, Sterling Professor of Immunobiology and professor of dermatology; of molecular, cellular and developmental biology; and of epidemiology (microbial diseases), discuss the association between long COVID and age, sex, race, and ethnicity.

Cases of dengue fever are surging at a record pace across South America and Puerto Rico. Dr. Albert Ko, MD, an infectious disease epidemiologist in the Yale School of Public Health’s Department of Epidemiology of Microbial Diseases, shares his insights about the current dengue public health threat in this installment of 3 Essential Questions.

A multidisciplinary team of Yale scientists has received a $4-million federal grant to study the effectiveness of a new vaccine and monoclonal antibody shot designed to prevent respiratory syncytial virus (RSV) in infants.